Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Hollander, E. Articles by Begaz, T. Search for Related Content PubMed Citation Articles by Hollander, E. Articles by Begaz, T. Other Addictive Disorders Antidepressants

Short-Term Single-Blind Fluvoxamine Treatment of Pathological Gambling

Objective:The authors' goal was to assess the efficacy and tolerability of the selective serotonin reuptake inhibitor fluvoxamine in the treatment of pathological gambling. Method:Sixteen patients with pathological gambling entered an 8-week placebo lead-in phase, and 10 of these patients completed an 8-week single-blind fluvoxamine trial.Results:Seven of the 10 patients who completed the fluvoxamine trial were judged treatment responders at the end of the study: 1) they had greater than 25% decreases in their gambling behavior scores on the pathological gambling modification of the Yale-Brown Obsessive Compulsive Scale, and 2) their clinician-rated Clinical Global Impression scores for gambling severity were very much improved or much improved. Fluvoxamine treatment resulted in gambling abstinence in seven of the 10 patients.Conclusions:Findings from this preliminary study suggest that fluvoxamine may be effective in reducing the urge to gamble. Randomized placebo-controlled and maintenance trials are required to confirm these findings and to determine whether improvement persists. Am J Psychiatry 1998; 155: 1781-1783

This article has been cited by other articles:

				J. Westermeyer, J. Canive, J. Garrard, P. Thuras, and J. Thompson Lifetime Prevalence of Pathological Gambling Among American Indian and Hispanic American Veterans Am J Public Health, May 1, 2005; 95(5): 860 - 866. [Abstract] [Full Text] [PDF]

				J. E. Grant and R. Grosz Pharmacotherapy Outcome in Older Pathological Gamblers: A Preliminary Investigation J Geriatr Psychiatry Neurol, March 1, 2004; 17(1): 9 - 12. [Abstract] [PDF]

				N. Gogtay, A. Sporn, L. S. Clasen, D. Greenstein, J. N. Giedd, M. Lenane, P. A. Gochman, A. Zijdenbos, and J. L. Rapoport Structural Brain MRI Abnormalities in Healthy Siblings of Patients With Childhood-Onset Schizophrenia Am J Psychiatry, March 1, 2003; 160(3): 569 - 571. [Abstract] [Full Text] [PDF]

				H. Ananth, I. Popescu, H. D. Critchley, C. D. Good, R. S.J. Frackowiak, and R. J. Dolan Cortical and Subcortical Gray Matter Abnormalities in Schizophrenia Determined Through Structural Magnetic Resonance Imaging With Optimized Volumetric Voxel-Based Morphometry Am J Psychiatry, September 1, 2002; 159(9): 1497 - 1505. [Abstract] [Full Text] [PDF]

				N. M. Petry and C. Armentano Prevalence, Assessment, and Treatment of Pathological Gambling: A Review Psychiatr Serv, August 1, 1999; 50(8): 1021 - 1027. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us